Brokerages Set Oscar Health, Inc. (NYSE:OSCR) Target Price at $17.00

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average recommendation of “Reduce” from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $17.00.

Several analysts have commented on the company. Barclays set a $18.00 price objective on Oscar Health and gave the company an “equal weight” rating in a research note on Monday, January 5th. Stephens began coverage on Oscar Health in a research note on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price target for the company. Wall Street Zen lowered shares of Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. The Goldman Sachs Group began coverage on shares of Oscar Health in a research note on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price objective on the stock. Finally, Wells Fargo & Company reduced their target price on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research note on Thursday, November 13th.

Insider Activity

In other Oscar Health news, CFO Richard Scott Blackley sold 25,135 shares of Oscar Health stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $416,989.65. Following the sale, the chief financial officer owned 1,351,034 shares of the company’s stock, valued at approximately $22,413,654.06. The trade was a 1.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Mario Schlosser sold 23,038 shares of the business’s stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.65, for a total value of $406,620.70. Following the transaction, the insider owned 350,180 shares in the company, valued at $6,180,677. The trade was a 6.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 483,307 shares of company stock worth $7,635,300 in the last three months. 25.11% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Rakuten Securities Inc. purchased a new stake in shares of Oscar Health during the 4th quarter worth $86,000. Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in shares of Oscar Health by 1,097.8% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock valued at $3,418,000 after purchasing an additional 218,022 shares during the period. TD Waterhouse Canada Inc. boosted its holdings in Oscar Health by 79.2% during the fourth quarter. TD Waterhouse Canada Inc. now owns 36,927 shares of the company’s stock worth $530,000 after buying an additional 16,322 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Oscar Health by 28.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 45,819 shares of the company’s stock worth $658,000 after buying an additional 10,009 shares in the last quarter. Finally, KBC Group NV grew its position in Oscar Health by 47.8% during the fourth quarter. KBC Group NV now owns 7,212 shares of the company’s stock worth $104,000 after buying an additional 2,332 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Up 0.1%

Shares of NYSE:OSCR opened at $14.90 on Thursday. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.80. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. The stock has a market cap of $3.94 billion, a P/E ratio of -13.30 and a beta of 1.90. The firm has a fifty day moving average price of $15.98 and a 200 day moving average price of $16.80.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business had revenue of $2.93 billion during the quarter, compared to analysts’ expectations of $3.09 billion. During the same period in the prior year, the company earned ($0.22) earnings per share. The business’s revenue was up 23.2% compared to the same quarter last year. Sell-side analysts predict that Oscar Health will post 0.69 EPS for the current year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.